Burning Rock Biotech annual operating margin
2018
2019
2020
2021
2022
2023
2024
2025
Burning Rock Biotech's operating margin was −10.16% for fiscal 2025.
View full Burning Rock Biotech company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −10.16% | +59.15 pp |
| 2024 | 2024-12-31 | −69.32% | +55.22 pp |
| 2023 | 2023-12-31 | −124.54% | +49.53 pp |
| 2022 | 2022-12-31 | −174.07% | −17.12 pp |
| 2021 | 2021-12-31 | −156.94% | −61.02 pp |
| 2020 | 2020-12-31 | −95.93% | −51.63 pp |
| 2019 | 2019-12-31 | −44.30% | +32.97 pp |
| 2018 | 2018-12-31 | −77.27% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Burning Rock Biotech's operating margin increased from −95.93% to −10.16%, a change of +85.77 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech filings at SEC.gov ↗